← back to search
Pingping Lai
King University
· US
Area of research
Epidemiology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Endocrinology, Internal medicine, Extracellular matrix, Fusion protein, Steatohepatitis, and Fibrosis.
h-index
—
citations
47
works
3
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment
Nature Communications
2024
cited by
32
position: middle
doi
Idol Depletion Protects against Spontaneous Atherosclerosis in a Hamster Model of Familial Hypercholesterolemia
Oxidative Medicine and Cellular Longevity
2022
cited by
8
position: middle
doi
Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia
Frontiers in Cardiovascular Medicine
2022
cited by
7
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Xunde Xian
· Home Office
3
papers (2022–2024)
Mingming Gao
· Hebei Medical University
2
papers (2022–2022)
Yuhui Wang
· Fudan University
2
papers (2022–2022)
Kenan Peng
· Hebei Medical University
1
papers (2022–2022)
Derfogail Delcassian
· Massachusetts Institute of Technology
1
papers (2024–2024)
Pengxia Qin
· Shandong University
1
papers (2024–2024)
Xinzhu Shan
· Shenyang Pharmaceutical University
1
papers (2024–2024)
Hongyuan Yang
· The University of Sydney
1
papers (2022–2022)
Wei Huang
· Peking University
1
papers (2022–2022)
Xueguang Lu
· Massachusetts Institute of Technology
1
papers (2024–2024)
Xinlin Hou
· Ningbo University
1
papers (2022–2022)
Wenxi Zhang
· Gladstone Institutes
1
papers (2022–2022)
Jiabao Guo
· King University
1
papers (2022–2022)
Yitong Xu
· Home Office
1
papers (2022–2022)
Yubin Ke
· Southern Medical University
1
papers (2024–2024)
Jiaao Ma
· Harbin Medical University
1
papers (2022–2022)
Yifan Ge
· Nantong University
1
papers (2024–2024)
Mingqi Zheng
· Hebei Medical University
1
papers (2022–2022)
—
·
1
papers (2024–2024)
Xin Chen
· Qingdao University
1
papers (2022–2022)